Royal Bank Of Canada En V Veno Medical Corp Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.24 - $6.19 $4,455 - $8,511	1,375 Added 1195.65%	1,490 $5,000
Q2 2024 Aug 14, 2024	BUY	$4.62 - $5.5 $480 - $572	104 Added 945.45%	115 $0
Q1 2024 Nov 05, 2024	SELL	$3.94 - $6.65 $409 - $691	-104 Reduced 90.43%	11 $0
Q1 2024 May 15, 2024	SELL	$3.94 - $6.65 $350 - $591	-89 Reduced 89.0%	11 $0
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.73 $190 - $315	55 Added 122.22%	100 $0
Q3 2023 Nov 14, 2023	SELL	$3.16 - $5.74 $148 - $269	-47 Reduced 51.09%	45 $0
Q2 2023 Aug 14, 2023	BUY	$2.6 - $5.19 $239 - $477	92 New	92 $0
Q3 2022 Nov 14, 2022	BUY	$0.1 - $7.82 $5 - $461	59 New	59 $0

4.33M

34.1K

2.5K

Ticker NVNO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 9,469,850
Market Cap $43.4M
Description
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.